tiprankstipranks
Cyteir Therapeutics (CYT)
NASDAQ:CYT
US Market
Holding CYT?
Track your performance easily

Cyteir Therapeutics (CYT) Technical Analysis

24 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
6Neutral
11Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Cyteir Therapeutics’s (CYT) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Cyteir Therapeutics is a Buy.
Cyteir Therapeutics’s (CYT) 20-Day exponential moving average is 3.06, while Cyteir Therapeutics’s (CYT) share price is $3.02, making it a Sell.
Cyteir Therapeutics’s (CYT) 50-Day exponential moving average is 3.07, while Cyteir Therapeutics’s (CYT) share price is $3.02, making it a Sell.

Cyteir Therapeutics (CYT) Pivot Points

Nov 24, 2024, 06:07 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.89
2.95
2.98
3.04
3.07
3.13
3.16
Fibonacci
2.95
2.98
3.00
3.04
3.07
3.09
3.13
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cyteir Therapeutics (CYT) Moving Averages

Nov 24, 2024, 06:07 AM
Period
Simple
Exponential
MA5
3.03Sell
3.03Sell
MA10
3.04Sell
3.05Sell
MA20
3.08Sell
3.06Sell
MA50
3.09Sell
3.07Sell
MA100
3.07Sell
3.02Sell
MA200
2.86Buy
2.79Buy
Cyteir Therapeutics’s (CYT) 10-Day exponential moving average is 3.05, while Cyteir Therapeutics’s (CYT) share price is $3.02, making it a Sell.
Cyteir Therapeutics’s (CYT) 100-Day exponential moving average is 3.02, while Cyteir Therapeutics’s (CYT) share price is $3.02, making it a Sell.
Cyteir Therapeutics’s (CYT) stock price is $3.02 and Cyteir Therapeutics’s (CYT) 50-day simple moving average is 3.09, creating a Sell signal.
Cyteir Therapeutics’s (CYT) stock price is $3.02 and Cyteir Therapeutics’s (CYT) 100-day simple moving average is 3.07, creating a Sell signal.
Cyteir Therapeutics’s (CYT) stock price is $3.02 and Cyteir Therapeutics’s (CYT) 200-day simple moving average is 2.86, creating a Buy signal.

Cyteir Therapeutics (CYT) Technical Indicators

Nov 24, 2024, 06:07 AM
Name
Value
Implied Action
RSI (14)
42.37
Neutral
STOCH (9,6)
38.19
Neutral
STOCHRSI (14)
38.19
Neutral
MACD (12,26)
-0.02
Buy
ADX (14)
22.23
Neutral
Williams %R
-66.67
Buy
CCI (14)
-89.90
Neutral
ATR (14)
0.08
-
Ultimate Oscillator
41.28
Neutral
ROC
-3.22
Sell
Cyteir Therapeutics’s (CYT) Relative Strength Index (RSI) is 42.37, creating a Neutral signal.
Cyteir Therapeutics’s (CYT) Trend Strength Indicator (ADX) is 22.23, creating a Neutral signal.
Cyteir Therapeutics’s (CYT) Commodity Channel Index (CCI) is -89.90, creating a Neutral signal.
Cyteir Therapeutics’s (CYT) Price Rate of Change (ROC) is -3.22, creating a Sell signal.

FAQ

Is CYT a Buy, Hold, or Sell?
Based on CYT’s technical indicators, CYT is a Sell.
    What is CYT’s RSI (14)?
    CYT’s RSI (14) is 42.37, which suggests CYT is a Neutral.
      What is CYT’s MACD?
      CYT’s MACD is -0.02, which suggests CYT is a Buy.
        What is CYT’s 5-day moving average?
        CYT’s 5-day moving average is 3.03, which suggests CYT is a Sell.
          What is CYT’s 20-day moving average?
          CYT 20-day moving average is 3.08, which suggests CYT is a Sell.
            What is CYT’s 50-day moving average?
            CYT’s 50-day moving average is 3.09, which suggests CYT is a Sell.
              What is CYT’s 200-day moving average?
              CYT’s 200-day moving average is 2.86, which suggests CYT is a Buy.
                What is CYT’s Williams % R (14)?
                CYT’s Williams % R (14) is -66.67, which suggests CYT is a Buy.
                  What is CYT’s CCI (14)?
                  CYT’s CCI (14) is -89.90, which suggests CYT is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis